Intravenous Infusions Plc (GHSE:IIL)

Ghana · Delayed Price · Currency is GHS

0.6400

-0.1400 (-17.95%)

At close: Aug 5, 2026

1,500% (1Y)

Market Cap	214.04M +1,850.0%
Revenue (ttm)	6.51M -66.4%
Net Income	-4.43M
EPS	-0.01
Shares Out	274.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	295,788
Open	n/a
Previous Close	0.7800
Day's Range	n/a
52-Week Range	0.0400 - 0.8600
Beta	-0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Intravenous Infusions

Intravenous Infusions Plc, a pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. It provides pethidine, such as chloroquine phosphate and quinine dihydrochloride injections. The company was incorporated in 1969 and is based in Koforidua, Ghana. [Read more]

Industry Pharmaceutical Preparations

Founded 1969

Country Ghana

Stock Exchange Ghana Stock Exchange

Ticker Symbol IIL

Full Company Profile

Financial Performance

In 2025, Intravenous Infusions's revenue was 9.30 million, a decrease of -62.69% compared to the previous year's 24.94 million. Losses were -4.63 million, 620.5% more than in 2024.

Financial Statements